This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Shenzhen Zhongge Biological Technology Co., Ltd., Ningbo Combireg Pharmaceutical Technology Co., Ltd., Shenzhen Salubris Pharmaceuticals Co. Ltd.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Innovations of Xiaoming Wen in Pharmaceutical Technology.
Introduction
Xiaoming Wen is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceutical manufacturing technology. His work focuses on developing innovative solutions that enhance the efficacy of pharmaceutical compositions.
Latest Patents
Xiaoming Wen holds a patent for a pharmaceutical composition of a docetaxel conjugate and its preparation method. This invention provides a novel pharmaceutical composition that is preferably administered by injection. The docetaxel conjugate has a structural formula as shown in the following formula: (I). This innovation aims to improve the delivery and effectiveness of the drug in treating various conditions.
Career Highlights
Throughout his career, Xiaoming Wen has worked with prominent companies in the pharmaceutical industry. He has been associated with Shenzhen Salubris Pharmaceuticals Co. Ltd. and Ningbo Combireg Pharmaceutical Technology Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical technology.
Collaborations
Xiaoming Wen has collaborated with several professionals in his field. Notable coworkers include Gang Liu and Xuan Zhang. Their collective efforts have further advanced the research and development of pharmaceutical innovations.
Conclusion
Xiaoming Wen's contributions to pharmaceutical technology, particularly through his patent on docetaxel conjugates, highlight his role as an influential inventor. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile